Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $15,161 - $17,190
-316 Reduced 3.3%
9,269 $503 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $464,680 - $554,492
9,585 New
9,585 $492 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Team Hewins, LLC Portfolio

Follow Team Hewins, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Team Hewins, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Team Hewins, LLC with notifications on news.